Total Payments
$1.5M
2024 Payments
$169,360
Companies
11
Transactions
1,341
Medicare Patients
1,575
Medicare Billing
$143,951
Payment Breakdown by Category
Other$1.2M (77.9%)
Travel$168,435 (11.0%)
Consulting$145,055 (9.4%)
Food & Beverage$26,019 (1.7%)
Education$63.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.2M | 504 | 77.9% |
| Travel and Lodging | $168,435 | 430 | 11.0% |
| Consulting Fee | $145,055 | 40 | 9.4% |
| Food and Beverage | $26,019 | 365 | 1.7% |
| Education | $63.00 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $534,839 | 557 | $0 (2024) |
| GlaxoSmithKline, LLC. | $528,123 | 382 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $156,988 | 134 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $111,523 | 102 | $0 (2019) |
| GENZYME CORPORATION | $109,114 | 83 | $0 (2024) |
| Genentech USA, Inc. | $58,349 | 46 | $0 (2022) |
| Merck Sharp & Dohme LLC | $13,279 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11,235 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $7,077 | 5 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $6,714 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169,360 | 109 | AstraZeneca Pharmaceuticals LP ($67,131) |
| 2023 | $172,248 | 153 | GlaxoSmithKline, LLC. ($100,189) |
| 2022 | $170,124 | 139 | GlaxoSmithKline, LLC. ($86,671) |
| 2021 | $123,313 | 88 | GlaxoSmithKline, LLC. ($85,954) |
| 2020 | $96,234 | 74 | GlaxoSmithKline, LLC. ($95,467) |
| 2019 | $365,763 | 312 | AstraZeneca Pharmaceuticals LP ($143,449) |
| 2018 | $247,234 | 253 | AstraZeneca Pharmaceuticals LP ($160,444) |
| 2017 | $192,984 | 213 | AstraZeneca Pharmaceuticals LP ($88,687) |
All Payment Transactions
1,341 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,643.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,643.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,888.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,888.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,153.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,418.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,153.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $576.90 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $375.29 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,888.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,723.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $464.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $870.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $824.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,398.00 | General |
| Category: Immunology | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $120.82 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $77.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,438.00 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $2,576.97 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $390.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 399 | 418 | $108,576 | $37,804 |
| 2022 | 8 | 423 | 433 | $98,975 | $36,745 |
| 2021 | 6 | 397 | 405 | $99,800 | $38,062 |
| 2020 | 6 | 356 | 364 | $89,885 | $31,340 |
Total Patients
1,575
Total Services
1,620
Medicare Billing
$143,951
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 90 | 109 | $22,681 | $12,561 | 55.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 67 | 67 | $19,682 | $9,150 | 46.5% |
| 31625 | Biopsy of lung airway using an endoscope | Facility | 2023 | 60 | 60 | $24,660 | $7,219 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 45 | 45 | $6,865 | $3,535 | 51.5% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 64 | 64 | $14,610 | $3,518 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $2,613 | $1,077 | 41.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 62 | 62 | $17,465 | $744.30 | 4.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 74 | 80 | $16,400 | $9,476 | 57.8% |
| 31625 | Biopsy of lung airway using an endoscope | Facility | 2022 | 65 | 65 | $26,170 | $8,020 | 30.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 43 | 43 | $12,470 | $6,349 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 64 | $9,600 | $5,107 | 53.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 76 | 77 | $17,325 | $4,246 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 24 | 24 | $5,640 | $2,624 | 46.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 66 | 66 | $10,390 | $559.08 | 5.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 14 | 14 | $980.00 | $363.82 | 37.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 91 | 99 | $20,295 | $11,838 | 58.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 69 | 69 | $20,010 | $10,374 | 51.8% |
| 31625 | Biopsy of lung airways using an endoscope | Facility | 2021 | 71 | 71 | $28,630 | $8,871 | 31.0% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2021 | 60 | 60 | $13,500 | $3,303 | 24.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 30 | $4,500 | $2,444 | 54.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 76 | 76 | $12,865 | $1,232 | 9.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 76 | 76 | $22,040 | $10,464 | 47.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 93 | 101 | $20,705 | $9,263 | 44.7% |
| 31625 | Biopsy of lung airways using an endoscope | Facility | 2020 | 60 | 60 | $23,640 | $7,329 | 31.0% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2020 | 50 | 50 | $11,250 | $2,792 | 24.8% |
About Dr. Ronald Balkissoon, MD
Dr. Ronald Balkissoon, MD is a Pulmonary Disease healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013926468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Balkissoon, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $169,360 received in 2024. These payments were reported across 1,341 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.2M).
As a Medicare-enrolled provider, Balkissoon has provided services to 1,575 Medicare beneficiaries, totaling 1,620 services with total Medicare billing of $143,951. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Denver, CO
- Active Since 08/05/2006
- Last Updated 11/12/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1013926468
Products in Payments
- TRELEGY ELLIPTA (Drug) $248,055
- FASENRA (Drug) $225,630
- DUPIXENT (Biological) $182,611
- BEVESPI AEROSPHERE (Drug) $125,040
- BREZTRI (Drug) $97,991
- NUCALA (Biological) $87,679
- AREXVY (Drug) $69,045
- UTIBRON (Drug) $68,626
- DUPIXENT (Drug) $53,370
- AIRSUPRA (Drug) $34,487
- LONHALA MAGNAIR (Drug) $33,438
- Xolair (Biological) $25,360
- ANORO (Drug) $19,247
- SYMBICORT (Drug) $13,835
- SHINGRIX (Biological) $10,400
- DALIRESP (Drug) $9,957
- DUPIXENT DUPILUMAB INJECTION (Biological) $7,772
- XOLAIR (Biological) $6,691
- BROVANA (Drug) $4,810
- ANORO ELLIPTA (Drug) $3,729
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Denver
Kevin Brown, Md, MD
Pulmonary Disease — Payments: $333,953
Pulmonary Disease $333,953
David Griffith, Md, MD
Pulmonary Disease — Payments: $287,061
Pulmonary Disease $287,061
Barry Make, Md, MD
Pulmonary Disease — Payments: $244,103
Pulmonary Disease $244,103
Dr. David Beuther, Md, MD
Pulmonary Disease — Payments: $155,207
Pulmonary Disease $155,207
Evans Fernandezperez, M.d, M.D
Pulmonary Disease — Payments: $149,782
Pulmonary Disease $149,782
Dr. Robert Sandhaus, M.d., Ph.d, M.D., PH.D
Pulmonary Disease — Payments: $106,680
Pulmonary Disease $106,680